(Q43838003)

English

Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: relationship to disease characteristics

scientific article published in October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: relationship to disease characteristics (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

adult acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

S Aref

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Mabed

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Sakrana

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

T Goda

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M El-Sherbiny

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

273-279

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Increased angiogenesis and Fas-ligand expression are independent processes in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Angiogenesis in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Angiogenesis in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Basic fibroblast growth factor stimulates hepatocyte growth factor/scatter factor secretion by human mesenchymal cells

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Elevated levels of angiogenic cytokines in the plasma of cancer patients.

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Expression of endothelial cell-associated molecules in AML cells

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Measurement of hepatocyte growth factor in serum and plasma

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Partial characterization of a hepatocyte growth factor from rat platelets

1 reference

https://api.crossref.org/works/10.1080%2F1024533021000037207

21 January 2018

Identifiers

10.1080/1024533021000037207

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43838003&oldid=2103772903"